Biogen Inc (NASDAQ:BIIB)

303.07
BATS BZX Real-Time Price
As of 11:19am ET
 -1.95 / -0.64%
Today’s Change
187.16
Today|||52-Week Range
311.88
+26.32%
Year-to-Date
Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal
7:55am / Zacks.com - Paid Partner Content
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Nov 28 / Zacks.com - Paid Partner Content
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?
Dec 01 / Zacks.com - Paid Partner Content
2 Stocks Near 52-Week Highs That Could Climb Higher
Nov 28 / MotleyFool.com - Paid Partner Content
Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug
Dec 01 / Zacks.com - Paid Partner Content
Why Is BioMarin (BMRN) Up 14.1% Since Last Earnings Report?
Nov 25 / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects
Nov 30 / Zacks.com - Paid Partner Content
Why Is Biogen Inc. (BIIB) Up 8.2% Since Last Earnings Report?
Nov 24 / Zacks.com - Paid Partner Content
Gilead (GILD) Gets EC Approval for Biktarvy Label Expansion
Nov 30 / Zacks.com - Paid Partner Content
Novartis (NVS) Set to Advance Malaria Drug Into Phase III
Nov 24 / Zacks.com - Paid Partner Content
Steven Cohen Loads Up on Workday, Dumps Coca-Cola
Nov 29 / GuruFocus News - Paid Partner Content
BIIB or RGEN: Which Is the Better Value Stock Right Now?
Nov 23 / Zacks.com - Paid Partner Content
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
Nov 29 / Zacks.com - Paid Partner Content
Regeneron's (REGN) Libtayo Gets EC Nod for Cervical Cancer
Nov 23 / Zacks.com - Paid Partner Content
CinCor (CINC) Tanks Due to Dismal Data on Hypertension Drug
Nov 29 / Zacks.com - Paid Partner Content
Is AMN Healthcare Services (AMN) Stock Outpacing Its Medical Peers This Year?
Nov 23 / Zacks.com - Paid Partner Content
Gilead (GILD), RCUS Announce Positive Data From NSCLC Study
Nov 29 / Zacks.com - Paid Partner Content